As of Jun 23
| +0.12 / +1.49%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 13.00, with a high estimate of 14.00 and a low estimate of 11.00. The median estimate represents a +58.54% increase from the last price of 8.20.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.